LLM returned non-JSON response. Review the filing manually.
Price Chart
Executive Summary
{ "summary": "NewAmsterdam Pharma issued a press release announcing participation in an upcoming investor conference, but did not report financial results. The filing references a prior earnings release where EPS was $-0.62, missing consensus of $-0.42, and revenue was $926K. No new financial data was provided.", "sentiment": "bearish", "impactScore": 5, "confidence": "medium", "keyFacts": [ "Press release announces investor conference participation, not new financial results",
Financial Impact
Unknown
Risk Factors
- Analysis may be incomplete
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3270040 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 15, 2026 17d ago | Insider Buy | $21.16 $23.32 | ▲ +10.21% | ▲ +8.08% | $23.20 (+9.64%) |
Aug 5, 2026 8w ago | 8-K | $27.42 $27.83 | ▲ +1.50% | ▲ +1.14% | $23.20 (−15.39%) |
Jul 24, 2026 10w ago | 8-K | $29.64 $28.46 | ▼ −3.98% | ▼ −4.35% | $23.20 (−21.73%) |
Apr 8, 2026 25w ago | Press Release | $34.01 $34.01 | · 0.00% | ▼ −3.52% | $23.20 (−31.78%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access